Drug Development

Articles

IDT Biologika completes large-scale biologics finishing facility in Dessau, Germany.

IDT Biologika Certifies Facility to Fill and Lyophilize Biologics and Vaccines

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The total market for biopharmaceuticals in 2013 was $36.8 billion according to Kalorama Information. Meanwhile, Frost & Sullivan estimates that the biosimilars market, which it pegged at just $1.2 billion in 2013, will grow to $23 billion in 2019, or more than 20-fold increase.

Focus on Biosimilars

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Pharmaceutical Technology Europe spoke with Piero Iamartino, R&D director at Micro-Macinazione, about the role of micronization in pharmaceutical manufacturing.

Micronization as a Bioavailability Enhancement Tool

LABOCHIM SpA completes construction on multipurpose high-potent API plant in Milan.

Milan API Producer Opens High-Potent API Plant

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Demand for new therapies and vaccines spotlights production challenges.

Biopharma Manufacturers Respond to Ebola Crisis

Weighing the pros and cons of hot-melt extrusion and spray drying.

Solving Poor Solubility with Amorphous Solid Dispersions

Sean Milmo is a freelance writer based in Essex, UK.

Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines.

Harmonizing Marketing Approval of Generic Drugs in Europe

Advances in solid and liquid formulation techniques are providing more options.

New Technologies Enhance the Formulation of Highly Potent Drugs

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

NIH seeks new therapeutic products to bolster the protective properties of vaccines.

NIH Seeks to Improve Vaccine Response with New Adjuvants

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

Formulation and Drug Delivery